Calix Valuation

Is CXL undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • PM vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of CXL when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate CXL's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate CXL's fair value for valuation analysis.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for CXL?

Other financial metrics that can be useful for relative valuation.

CXL key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue12.6x
Enterprise Value/EBITDA-11.8x
PEG Ration/a

Price to Sales Ratio vs Peers

How does CXL's PS Ratio compare to its peers?

The above table shows the PS ratio for CXL vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average1.2x
CG1 Carbonxt Group
2.1xn/aAU$30.8m
SDV SciDev
0.5x9.7%AU$47.5m
SES SECOS Group
1xn/aAU$21.5m
ORI Orica
1x4.0%AU$8.2b
CXL Calix
14.6x40.9%AU$322.9m

Price-To-Sales vs Peers: CXL is expensive based on its Price-To-Sales Ratio (14.6x) compared to the peer average (1.2x).


Price to Earnings Ratio vs Industry

How does CXL's PE Ratio compare vs other companies in the AU Chemicals Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a19.5%
n/an/an/a
No. of CompaniesPS048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a19.5%
n/an/an/a
No more companies

Price-To-Sales vs Industry: CXL is expensive based on its Price-To-Sales Ratio (14.6x) compared to the Australian Chemicals industry average (3.1x).


Price to Sales Ratio vs Fair Ratio

What is CXL's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CXL PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio14.6x
Fair PS Ratio3.9x

PM vs Fair Ratio: CXL is expensive based on its Price-To-Sales Ratio (14.6x) compared to the estimated Fair Price-To-Sales Ratio (3.9x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst CXL forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentAU$1.78
AU$5.77
+224.0%
24.1%AU$7.70AU$4.50n/a3
Feb ’25AU$1.70
AU$6.27
+268.6%
17.2%AU$7.70AU$5.10n/a3
Jan ’25AU$3.43
AU$6.98
+103.6%
10.3%AU$7.70AU$6.00n/a3
Dec ’24AU$3.47
AU$6.98
+101.2%
10.3%AU$7.70AU$6.00n/a3
Nov ’24AU$2.82
AU$6.98
+147.6%
10.3%AU$7.70AU$6.00n/a3
Oct ’24AU$2.82
AU$8.27
+193.1%
22.2%AU$10.50AU$6.00n/a3
Sep ’24AU$3.87
AU$8.27
+113.6%
22.2%AU$10.50AU$6.00n/a3
Aug ’24AU$4.13
AU$8.50
+105.8%
22.0%AU$10.50AU$6.00n/a3
Jul ’24AU$4.17
AU$8.50
+103.8%
22.0%AU$10.50AU$6.00n/a3
Jun ’24AU$4.16
AU$8.50
+104.3%
22.0%AU$10.50AU$6.00n/a3
May ’24AU$4.74
AU$8.50
+79.3%
22.0%AU$10.50AU$6.00n/a3
Apr ’24AU$4.74
AU$8.50
+79.3%
22.0%AU$10.50AU$6.00n/a3
Mar ’24AU$5.60
AU$8.50
+51.8%
22.0%AU$10.50AU$6.00AU$1.783
Feb ’24AU$5.44
AU$8.50
+56.2%
22.0%AU$10.50AU$6.00AU$1.703
Jan ’24AU$4.47
AU$8.25
+84.6%
27.3%AU$10.50AU$6.00AU$3.432
Dec ’23AU$5.15
AU$8.25
+60.2%
27.3%AU$10.50AU$6.00AU$3.472
Nov ’23AU$4.30
AU$8.00
+86.0%
25.0%AU$10.00AU$6.00AU$2.822
Oct ’23AU$5.78
AU$9.25
+60.1%
8.1%AU$10.00AU$8.50AU$2.822
Sep ’23AU$6.68
AU$9.25
+38.5%
8.1%AU$10.00AU$8.50AU$3.872
Aug ’23AU$6.25
AU$9.43
+50.8%
12.5%AU$10.60AU$8.25AU$4.132
Jul ’23AU$5.92
AU$9.43
+59.2%
12.5%AU$10.60AU$8.25AU$4.172
Jun ’23AU$7.92
AU$9.35
+18.1%
10.3%AU$10.60AU$8.25AU$4.163
May ’23AU$8.80
AU$8.78
-0.3%
20.8%AU$10.60AU$6.95AU$4.742
Apr ’23AU$7.65
AU$7.07
-7.6%
8.5%AU$7.85AU$6.40AU$4.743
Mar ’23AU$5.99
AU$6.92
+15.5%
9.6%AU$7.85AU$6.40AU$5.603

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies

Price7D1Y
Mkt CapP/EGrowth
Price7D1Y
Mkt CapP/EGrowth
Price7D1Y
Mkt CapP/EGrowth
Price7D1Y
Mkt CapP/EGrowth
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.